Phase II study of continuation maintenance by use of TS1 after induction chemotherapy of cisplatin and TS1 in patients with Stage IIIB / IV non-small cell lung cancer-Research of efficacy predictive biomarker
Phase of Trial: Phase II
Latest Information Update: 09 Apr 2019
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin
- Indications Non-small cell lung cancer
- Focus Biomarker; Therapeutic Use
- 30 Mar 2019 Status changed from recruiting to discontinued.
- 01 Feb 2019 Planned End Date changed from 31 Aug 2021 to 31 Mar 2019.
- 29 Sep 2018 Planned End Date changed from 1 Mar 2016 to 31 Aug 2021.